-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623.O2.6 623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Targeted Therapy Clinically Relevant Abstract

Symposia: Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Biological therapies, Antibody Therapy, Clinical Practice (Health Services and Quality), Lymphomas, Non-Biological therapies, Chemotherapy, Diseases, indolent lymphoma, Therapies, Lymphoid Malignancies
Monday, December 11, 2023: 4:30 PM-6:00 PM
Grand Hall C (Manchester Grand Hyatt San Diego)
Moderators:
Wojciech Jurczak, MD, PhD, MSC National Research Institute of Oncology and Rahul Lakhotia, MBBS, National Cancer Institute, National Institutes of Health
Disclosures:
Jurczak: Abbvie, Astra Zeneca, Bayer, BeiGene, Celtrion, Celgene, Debbiopharm, Epizyme, Incyte, Janssen, Loxo Oncology, Merck, Mei Pharma, Morphosys, Novo Nordisk, Roche, Sandoz, Takeda, TG Therapeutics: Research Funding; Astra Zeneca, BeiGene, Janssen, Loxo Oncology, Sandoz, Roche: Consultancy.
4:30 PM

Vincent Ribrag, MD1, Violaine Safar, MD2*, Hanneke Kluin-Nelemans3*, Lucie Oberic, MD4*, Pierre Feugier5*, Olivier Casasnovas, MD6*, Catherine Thieblemont, MD7*, Nicolas Daguindau8*, Gandhi Laurent Damaj, MD, PhD9*, Eva Hoster10*, Ludwig Fischer von Weikersthal11, Mathias Hänel, MD12, Marc Andre, MD, PhD13*, Maria Gomes Da Silva14*, Ana Marín Niebla15*, Michal Taszner16*, Jan Walewski17, Rinske Boersma, MD18*, Marie-Helene Delfau-Larue19*, Steven Le Gouill, MD, PhD20 and Martin Dreyling, MD21,22

1Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy Institute of Cancer,, Villejuif, France
2Hematology Department, Hôpital Lyon Sud - HCL, Lyon, France
3University Medical Center Groningen, University of Groningen, Groningen, NLD
4Hematology Department, IUCT - Oncopole, Toulouse, Toulouse, FRA
5CHU Brabois - Service d'Hématologie, Nancy, France
6Department of Hematology, Centre Hospitalier Universitaire Dijon, Dijon, France
7Hopital Saint-Louis, Paris, France
8Hematologie, Centre Hospitalier Annecy Genevois, Metz-Tessy, FRA
9CHU Caen, Caen, Normandy, FRA
10Institute of Medical Data Processing, Biometrics and Epidemiology (IBE), LMU Munich, Munich, Germany
11Gesundheitszentrum St. Marien GmbH, Amberg, Bavaria, DEU
12Department of Internal Medicine III, Hematology, Oncology and Cellular Therapies, Hospital Chemnitz, Chemnitz, Germany
13Department of Hematology, Saint-Luc - UCLouvain, BRUSSELS, Belgium
14Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, PRT
15Department of Hematology University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
16Department of Hematology and Transplantology, University Clinical Center, Medical University of Gdańsk, Gdańsk, Poland
17Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland
18Department of Internal Medicine, Amphia Ziekenhuis, Breda, Netherlands
19hopital henri modor, Creteil, FRA
20Hematology Department, Institut Curie, Paris, France
21Department of Medicine, Medical Clinic III, Ludwig-Maximilians-University Hospital, Munich, Germany
22Medizinische Klinik III, Klinikum der Universität, LMU München, Munich, Germany

4:45 PM

Clementine Sarkozy1*, Mary Callanan2*, Catherine Thieblemont, MD3*, Lucie Oberic, MD4*, Barbara Burroni, MD5*, Krimo Bouabdallah, MD6*, Gandhi Laurent Damaj, MD, PhD7*, Benoit Tessoulin8*, Vincent Ribrag, MD9, Roch Houot, MD, PhD10*, Franck Morschhauser, MD PhD11, Victoria Cacheux12*, Vincent Delwail13*, Violaine Safar, MD14,15*, Remy Gressin, MD16*, Morgane Cheminant17*, Olivier Hermine17, Elizabeth A. Macintyre, MD, PhD18 and Steven Le Gouill, MD, PhD19

1institut Curie, Saint Cloud, France
2CHU Dijon, Dijon, France
3Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncologie, Université de Paris, Paris, France
4Hematology Department, IUCT - Oncopole, Toulouse, Toulouse, FRA
5Pathology, Cochin, Paris, FRA
6CHU Bordeaux Pessac, Bordeaux, FRA
7CHU Caen, Caen, Normandy, FRA
8Hematology Department, CHU Nantes, Nantes, France
9Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy Institute of Cancer,, Villejuif, France
10Centre Hospitalier Universitaire Rennes, Université de Rennes, Rennes Cedex, FRA
11Hôpital Claude Huriez Univ. Lille, CHU Lille, Lille, France
12CHU Estaing, Clermont Ferrand, FRA
13Hematology, CHU Poitiers, Poitiers, FRA
14Hematology, CHLS, CHU Lyon, Pierre Bénite, France
15Hematology Department, Hôpital Lyon Sud - HCL, Lyon, France
16HOPITAL ALBERT MICHALLON, Department of Hematology, University Hospital Grenoble, Grenoble, France
17Department of Hematology, Necker Hospital, APHP, Paris, France
18Laboratory of Onco-Hematology, Necker Enfants-Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France, Paris, FRA
19Hematology Department, Institut Curie, Paris, France

5:00 PM

Jonathon B. Cohen, MD, MS1, Nirav N. Shah, MD2, Wojciech Jurczak, MD, PhD3, Pier Luigi Zinzani, MD, PhD4, Chan Y. Cheah, MBBS, FRACP, FRCPA, DMSc5, Toby A. Eyre6*, Chaitra S Ujjani, MD7, Youngil Koh, MD8, Won Seog Kim, MD, MPH, PhD9*, Sunita D. Nasta, MD, FACP10*, Ian W. Flinn, MD, PhD11, Benoit Tessoulin12*, Shuo Ma, MD, PhD13, Alvaro J. Alencar, MD14, David Lewis, MBChB, PHD15*, Jennifer A. Woyach, MD16, Kami J. Maddocks, MD16, Krish Patel, MD17, Yucai Wang, MD, PhD18, Joanna M. Rhodes, MD, MSCE19*, Constantine S. Tam, MD, MBBS20, John F. Seymour, MBBS, PhD, FRACP21, Hirokazu Nagai, MD, PhD22, Julie M. Vose, MD, MBA23, Bita Fakhri, MD, MPH24, Marc Hoffmann, MD25, Francisco J. Hernandez-Ilizaliturri, MD26, Andrew D. Zelenetz, MD, PhD27, Anita Kumar, MD27, Talha Munir, MBBS, MRCP, FRCPath, PhD28*, Donald E. Tsai, MD, PhD29*, Minna Balbas, PhD29*, Bin Liu, MSc, MPH29*, Amy S. Ruppert, PhD30*, Bastien Nguyen, PhD29*, Lindsey E. Roeker, MD27 and Michael L. Wang, MD31

1Winship Cancer Institute, Emory University, Atlanta, GA
2Medical College of Wisconsin, Milwaukee, WI
3Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
4Institute of Hematology “Seràgnoli”, University of Bologna, Bologna, Italy
5Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
6Oxford University Hospitals NHS Trust, Oxford, United Kingdom
7Fred Hutchinson Cancer Research Center, Seattle, WA
8Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea, Republic of (South)
9Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea, Republic of (South)
10Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
11Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN
12Hematology Department, University Hospital, Nantes, France
13Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
14Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
15University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
16The Ohio State University Comprehensive Cancer Center, Columbus, OH
17Swedish Cancer Institute, Seattle, WA
18Division of Hematology, Mayo Clinic, Rochester, MN
19Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
20The Alfred Hospital and Monash University, Melbourne, VIC, Australia
21Peter MacCallum Cancer Center, Royal Melbourne Hospital and University of Melbourne, Melbourne, VIC, Australia
22Department of Hematology and Oncology Research, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan
23University of Nebraska Medical Center, Omaha, NE
24Stanford University School of Medicine, Stanford, CA
25University of Kansas Cancer Center, Overland Park, KS
26Roswell Park Comprehensive Cancer Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY
27Memorial Sloan Kettering Cancer Center, New York, NY
28Department of Haematology, St. James's University Hospital, Leeds, United Kingdom
29Loxo@Lilly, Indianapolis, IN
30Eli Lilly and Company, Indianapolis, IN
31MD Anderson Cancer Center, Houston, TX

5:15 PM

Carola Boccomini, MD1*, Barbara Botto1*, Andrea Evangelista2*, Vittorio Ruggero Zilioli3*, Antonella Anastasia, MD4*, Federica Cavallo5*, Francesco Merli, MD6*, Manuela Zanni, MD7*, Monica Tani8*, Annalisa Chiarenza, MD9*, Anna Marina Liberati, MD10, Annarita Conconi, MD11*, Paolo Corradini, MD12, Alessia Bari, MD13*, Giorgia Annechini, MD14*, Gianluca Gaidano, MD, PhD15, Michele Spina, MD16*, Roberto Sartori, MD17*, Claudia Castellino, MD18*, Benedetta Puccini, MD19*, Annalisa Arcari, MD20*, Sara Bigliardi, MD21*, Giorgia Matta, MD22*, Michele Merli23*, Donato Mannina, MD24*, Dario Marino, MD, PhD25*, Piero Galieni, MD26*, Fabrizio Ciambelli, MD27*, Gerardo Musuraca, MD, PhD28*, Chiara Bottelli, MD4*, Cristina Muzi, MD3*, Simone Ferrero, MD5*, Stefano Luminari, MD6, Marco Ladetto29, Giovannino Ciccone, MD2* and Umberto Vitolo, MD30

1SC Ematologia, AOU Città della Salute e della Scienza, Torino, Italy
2SSD Epidemiologia Clinica e Valutativa, AOU Città della Salute e della Scienza e CPO Piemonte, Torino, Italy
3Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
4Hematology, ASST Spedali Civili, Brescia, Italy
5Division of Hematology and Stem Cell Transplant Unit, AOU Città della Salute e della Scienza, Torino, Italy
6S.C. Ematologia AUSL, IRCCS, Reggio Emilia, Italy
7Department of Translational Medicine, Università del Piemonte Orientale SCDU Ematologia, AO SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
8Ematologia, Ospedale Santa Maria delle Croci, Ravenna, Italy
9UOC Ematologia, Azienda Ospedaliera Universitaria Policlinico - San Marco, Catania, Italy
10Oncohematology Unit, Azienda Ospedaliera Santa Maria di Terni, University, Perugia, Italy
11SSD Ematologia, Nuovo Ospedale degli Infermi, Biella, Italy
12Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
13UO Oncologia, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy
14Hematology, Department of Translational and Precision Medicine, Sapienza University, Roma, Italy
15Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Novara, ITA
16Division of Medical Oncology, IRCCS Centro Di Riferimento Oncologico, Aviano, Italy
17Ematologia Ospedale di Castelfranco Veneto, Castelfranco Veneto, Italy
18SC Ematolgoa, Ospedale Santa Croce e Carle, Cuneo, Italy
19Unitа Ematologia, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy
20UO Ematologia, Ospedale Guglielmo da Saliceto, Piacenza, Italy
21DH Oncologico, Nuovo Ospedale Civile, Sassuolo, Italy
22SS Ematologia, Ospedale di Ciriè Chivasso e Ivrea - Ospedali Riuniti del Canavese, Ivrea, Italy
23UOC Ematologia, Ospedale di Circolo, Varese, Italy
24SC Ematologia, Azienda Ospedali Riuniti Papardo, Messina, Italy
25Oncologia 1, IRCCS Istituto Oncologico Veneto, Padova, Italy
26UOC Ematologia, Ospedale C.e G. Mazzoni, Ascoli Piceno, Italy
27SC Ematologia, ASST Valle Olona - Ospedale di Circolo, Busto Arsizio, Italy
28IRCCS Istituto Romagnolo per lo studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
29Department of Translational Medicine, Università del Piemonte Orientale SCDU Ematologia SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
30Onco-Ematologia, Candiolo Cancer Institute- Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Italy

5:30 PM

Paolo Strati, MD1, Lei Feng, MS2*, Jason Westin, MD3, Ranjit Nair, MD4, Luis Fayad, MD5, Maria Alma Rodriguez, MD6*, Dai Chihara, MD, PhD1, Luis Malpica, MD7*, Jared Henderson8*, Mariana Gallardo9*, Mario L. Marques-Piubelli, MD10, Polina Turova11*, Aleksandr Zaitsev, MSc12*, Iris Wang11*, Christopher R. Flowers, MD, MS1, Loretta J. Nastoupil, MD13 and Sattva S. Neelapu, MD1

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2Biostatistics, UT MD Anderson Cancer Center, Houston, TX
3Department of Lymphoma and Myeloma, The University of Texas M D Anderson Cancer Center, Houston, TX
4Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
5Lymphoma/Myeloma, M.D. Anderson Cancer Center, Houston, TX
6M.D. Anderson Cancer Ctr. University of Texas, Houston, TX
7Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
9The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
11Bostongene, Boston
12BostonGene, Corp., Waltham, MA
13MD Anderson Cancer Center, Houston, TX

5:45 PM

Juan Pablo Alderuccio, MD1, Alvaro J. Alencar, MD2, Jonathan H. Schatz, MD3, Russ Kuker, MD4*, Georgio Pongas, MD5*, Isildinha M. Reis, PhD6*, Jay Y. Spiegel, MD, FRCPC7, Laura Medina Andara5*, Lazaros J. Lekakis8*, Joseph S. Gyedu5*, Jose Sandoval-Sus, MD9, Amer M. Beitinjaneh, MD, MS10*, Nathalie Padron5*, Izidore S. Lossos, MD1, Joseph D. Rosenblatt, MD11*, David S. Lessen, MD5* and Craig H. Moskowitz, MD12

1Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami School of Medicine, Miami, FL
2Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
3University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
4Department of Radiology, Division of Nuclear Medicine, University of Miami, Miller School of Medicine, Miami, FL
5Sylvester Comprehensive Cancer Center, Miami
6Department of Public Health Sciences and Biostatistics and Bioinformatics Shared Resource, University of Miami Miller School of Medicine, Miami, FL
7Miller School of Medicine, University of Miami, Miami, FL
8Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL
9H Lee Moffitt Cancer Center at Memorial Cancer Institute, Ft Lauderdale, FL
10University of Miami, Miami, FL
11University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
12Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables, FL

*signifies non-member of ASH